Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Cash & Equivalents Growth (1y) (2022 - 2026)

Analysis

Bioregenx (BRGX) Cash & Equivalents Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn -26.57%
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn -19.91%
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 32.84%
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 42.78%
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 0.94%
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn -11.19%
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn -4.66%
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn 21.48%
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn -3.76%
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -45.22%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.22%
Dec 31, 2025 18.80%
Sep 30, 2025 -33.01%
Jun 30, 2025 -19.06%
Mar 31, 2025 -26.75%
Dec 31, 2024 -53.43%
Sep 30, 2024 9,145.51%
Dec 31, 2023 18,450.59%
Sep 30, 2023 -50.81%
Dec 31, 2022 -97.22%
API Access

Bioregenx Cash & Equivalents Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-1y&ticker=BRGX&period=max&api_key=YOUR_API_KEY